Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Helmet-like device safely increases hair density for people with hair loss.

Trichohyalin and peptidylarginine deiminase type III are found together in rat hair follicles, with trichohyalin being modified after expression.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

α-type filaments in guinea pig hair follicles have unique structural features.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Aromatase inhibitors cause male pattern hair loss in women.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

The treatment combination is effective and generally safe for lung cancer.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Some dibenzo compounds might help treat cancer with fewer side effects.